Lupus News

After years of too much quiet, there’s finally a lot going on in lupus around the world! Here are the latest major stories.

Thursday, August 19, 2010
FDA move means Benlysta could be approved by Dec. 9
Tuesday, July 13, 2010
Findings Could Lead to Lower Doses of Medication for Lupus Patients, Reducing Serious Side Effects
Monday, June 28, 2010
Articles and discussions on lupus research have ushered in a new era in disease management
Friday, June 18, 2010
LRI hails an increasingly efficacious picture for possible first new medication for lupus in over 50 years
Wednesday, June 16, 2010
New Data From EMBLEM™ Study Show Pipeline Drug Epratuzumab Provided Significant Efficacy for Patients Suffering From Moderate to Severe Systemic Lupus Erythematosus
Thursday, June 10, 2010
Says files Biologics License Application with FDA
Wednesday, June 9, 2010
Says to seek U.S. FDA approval by end June
Thursday, June 3, 2010
Maintenance phase of Aspreva Lupus Management Study (ALMS) successfully achieves primary endpoint
Tuesday, April 20, 2010
Human Genome Sciences (HGS) and GlaxoSmithKline Report Topline Results of 76-Week, Phase 3 Study
Wednesday, March 10, 2010
Thursday, February 25, 2010
Study finds SLE patients at risk for developing atherosclerosis
Thursday, February 11, 2010
Monday, February 8, 2010
Greater Baltimore Medical Center RN: Disease ‘helped me become better nurse’
Thursday, January 21, 2010
After decades of dead ends scientists find new treatments.
Monday, October 19, 2009
More Than a Dozen Different Genes May Play a Role in Causing Lupus
Sunday, September 13, 2009
Thursday, August 27, 2009
Positive Phase IIb results for UCB, Immunomedics drug